Spears M - Search Results

1

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.

Spears M, Lyttle N, D'Costa A, Chen BE, Yao CQ, Boutros PC, Burnell M, Levine MN, O'Brien P, Shepherd L, Bartlett JM. Spears M, et al. Oncotarget. 2016 Aug 2;7(31):49099-49106. doi: 10.18632/oncotarget.8542. Oncotarget. 2016. PMID: 27056899 Free PMC article. Clinical Trial.

2

The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.

Spears M, Bartlett J. Spears M, et al. Expert Opin Ther Targets. 2009 Jun;13(6):665-74. doi: 10.1517/14728220902911509. Expert Opin Ther Targets. 2009. PMID: 19456271 Review.

3

Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selection.

Spears M, Bartlett JM. Spears M, et al. Mol Diagn Ther. 2009 Dec 1;13(6):359-65. doi: 10.1007/BF03256341. Mol Diagn Ther. 2009. PMID: 19925033 Review.

4

Type I receptor tyrosine kinases as predictive or prognostic markers in early breast cancer.

Spears M, Kenicer J, Munro AF, Bartlett JM. Spears M, et al. Biomark Med. 2008 Aug;2(4):397-407. doi: 10.2217/17520363.2.4.397. Biomark Med. 2008. PMID: 20477393

5

The p160 ER co-regulators predict outcome in ER negative breast cancer.

Spears M, Oesterreich S, Migliaccio I, Guiterrez C, Hilsenbeck S, Quintayo MA, Pedraza J, Munro AF, Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. Breast Cancer Res Treat. 2012 Jan;131(2):463-72. doi: 10.1007/s10549-011-1426-1. Epub 2011 Mar 9. Breast Cancer Res Treat. 2012. PMID: 21390497

6

In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.

Spears M, Taylor KJ, Munro AF, Cunningham CA, Mallon EA, Twelves CJ, Cameron DA, Thomas J, Bartlett JM. Spears M, et al. Breast Cancer Res Treat. 2012 Apr;132(2):463-70. doi: 10.1007/s10549-011-1606-z. Epub 2011 Jun 3. Breast Cancer Res Treat. 2012. PMID: 21638049

7

Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression.

Spears M, Cunningham CA, Taylor KJ, Mallon EA, Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. J Pathol. 2012 Aug;227(4):481-9. doi: 10.1002/path.4022. Epub 2012 Apr 30. J Pathol. 2012. PMID: 22430898

8

Expression of activated type I receptor tyrosine kinases in early breast cancer.

Spears M, Pederson HC, Lyttle N, Gray C, Quintayo MA, Brogan L, J Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. Breast Cancer Res Treat. 2012 Jul;134(2):701-8. doi: 10.1007/s10549-012-2076-7. Epub 2012 May 5. Breast Cancer Res Treat. 2012. PMID: 22562124

9

Authors' reply.

Spears M, Cunningham CA, Taylor KJ, Mallon EA, Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. J Pathol. 2013 Feb;229(3):e2-3. doi: 10.1002/path.4144. J Pathol. 2013. PMID: 23152120 No abstract available.

10

Validated or not validated? That is the question.

Bartlett JM, Pritchard KI, Spears M. Bartlett JM, et al. Among authors: spears m. J Natl Cancer Inst. 2014 Jan;106(1):djt360. doi: 10.1093/jnci/djt360. J Natl Cancer Inst. 2014. PMID: 24402423 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page